Membrane glycoprotein PC-1 and insulin resistance

Molecular and Cellular Biochemistry

Volumn 182, Issue 1-2, 1998, Pages 177-184

  Goldfine, Ira D ^a   Maddux, Betty A ^a   Youngren, Jack F ^a   Frittitta, Lucia ^a   Trischitta, Vincenzo ^a   Dohm, G Lynis ^a  

^a Division of Diabetes Research   (United States)

Author keywords

Diabetes mellitus; Hyperglycemia; Insulin receptor; Membrane glycoprotein; Tyrosine kinase

Indexed keywords

GLYCOPROTEIN PC 1; INSULIN RECEPTOR; MEMBRANE PROTEIN; MUSCLE PROTEIN; PROTEIN TYROSINE KINASE; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; FIBROBLAST CULTURE; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOBLOTTING; INSULIN RESISTANCE; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN PHOSPHORYLATION; RECEPTOR GENE; SKELETAL MUSCLE; VASCULAR RESISTANCE;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; MEMBRANE GLYCOPROTEINS; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES;

EID: 0031894737     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006878001180     Document Type: Article

References (55)

1. Reaven GM: Role of insulin resistance in human disease. Diabetes 37: 1595-607, 1988
2. Kahn CR: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43: 1066-1084, 1994
3. Kraszynska YT, Olefsky JM: Cellular and molecular mechanisms of noninsulin dependent diabetes mellitus. J Invest Med 44: 423-428, 1996
4. Hamman RF: Genetic and environmental determinants of non-insulin-dependent-diabetes mellitus (NIDDM). Diabet/Metabol Rev 8: 287-338, 1992
5. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C: Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318: 1217-1225, 1988
6. Martin BC, Warrarn JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: Results of a 25-year follow-up study. Lancet 340: 925-929, 1992
7. Bogardus C, Lillioja S, Nyomba BL, Zurlo F, Swinburn B, Puente AE-D, Knowler WC, Ravussin ER, Mott DM, Bennett PH: Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. Diabetes 38: 1423-1432, 1989
8. Lillioja S, Mott DM, Zawadzki KK, Young AA, Abbott WGH, Knowler WC, Bennett PH, Moll P, Bogardus C: In vivo insulin action is a familial characteristic in nondiabetic Pima Indians. Diabetes 36: 1329-1335, 1987
9. Vaag A, Henriksen JE, Maclsbad S, Holm N, Beck-Nielsen H: Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest 95: 690-698, 1995
10. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven GM: Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 248: E286-E291, 1985
11. Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky JM: Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 44: 1121-1125, 1995
12. Brindley DN: Role of glucocorticoids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrome. Int J Obes Rel Metabol Disorders 19(suppl 1):S69-S75, 1995
13. Moller N, Jorgensen JD, Moller J, Orskov L, Ovesen P, Schmitz O, Christiansen JS, Orskov H: Metabolic effects of growth hormone in humans. Metabol Clin Exp 44(suppl 4): 33-36, 1995
14. DeMeyts P: The structural basis of insulin and insulin-like growth factor-1 receptor binding and negative cooperativity, and its relevance to mitogenic versus metabolic signaling. Diabetologia 37 (Suppl 2): S135-S148, 1994
15. Goldfine ID: The insulin receptor: Molecular biology and transmembrane signalling. Endocr Rev 8: 235-255, 1987
16. Kahn CR, White ME: The insulin receptor and the molecular mechanism of insulin action. J Clin Invest 82: 1151-1156, 1988
17. White ME: The IRS-1 signaling system. Curr Opin Genet Devel 4: 47-54, 1994
18. Moller DE, Flier JS: Insulin resistance-mechanisms, syndromes, and implications. New Eng J Med 325: 938-948, 1991
19. Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, Meelheim D, Dohm GL: Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 79: 1330-1337, 1987
20. Grasso G, Frittitta L, Anello M, Russo P, Susti G, Trischitta V: Insulin receptor tyrosine kinase activity is altered in both muscle and adipose tissue from nonobese normoglycemic insulin resistant subjects. Diabetologia 38: 55-61, 1995
21. Handberg A, Vaag A, Vinten J, Beck-Nielsen H: Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, nonobese first degree relatives of patients with type 2 (noninsulin-dependent) diabetes mellitus. Diabetologia 36: 668-674, 1993
22. Dunaif A, Xia J, Book C-B, Schenker E, Tang Z Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: A potential mechanism for insulin resistance in the Polycystic Ovary Syndrome. J Clin Invest 96: 801-810, 1995
23. Taylor SI: Lessons from patients with mutations in the insulin-receptor gene. Diabetes 41: 1473-1490, 1992
24. Yano T, Funakoshi I, Yamashina I: Purification and properties of nucleotide pyrophosphatase. J Biochem 98: 1097-1107, 1985
25. van Driel IR, Goding JW: Plasma cell membrane glycoprotein PC-1. J Biol Chem 262: 4882-4887, 1987
26. Harahap AR, Goding M Distribution of PC-1 in non lymphoid tissues. J Immunol 141: 2317-2320, 1988
27. Buckley MF, Loveland KA, McKinstry WJ, Garson OM, Goding JW: Plasma cell membrane glycoprotein PC-1 cDNA cloning of the human molecule, amino acid sequence, and chromosomal location. J Biol Chem 265: 17506-17511, 1990
28. Rebbe NF, Tong BD, Finley EM, Hickman S: Identification of nucleotide pyrophosphatase/alkaline phosphodiesterase I activity associated with the mouse plasma cell differentiation antigen PC-1. Proc Natl Acad Sci USA 88: 5192-5196, 1991
29. Funakoshi I, Kato H, Horie K, Yano T, Hori Y, Kobayashi H, Inoue T, Suzuki H, Fukui S, Tsukahara M, Kajii T, Yamashina I: Molecular cloning of human nucleotide pyrophosphatase. Arch Biochem Biophys 295: 180-187, 1992
30. Uriarte M, Stalmans W, Hickman S, Bollen M: Phosphorylation and nucleotide-dependent dephosphorylation of hepatic polypeptides related to the plasma cell differentiation antigen PC-1. B iochem J 293 : 93-100, 1993
31. Rebbe NF, Tong BID, Hickman S: Expression of nucleotide pyrophosphatase and alkaline phosphodiesterase I activities of PC-1, the murine plasma cell antigen. Mol Immunol 30: 87-93, 1993
32. Yoshida H, Fukui S, Funakoshi I, Yamashinal: Substrate specificity of a nucleotide pyrophosphatase responsible for the breakdown of 3'-phosphoadenosine 5′-phosphosulfate (PAPS) from human placenta. J Biochem 93: 1641-1648, 1983
33. Kawagoe H, Soma O, Goji J, Nishimura N, Narita M, Inazawa J, Nakamura H, Sano K: Molecular cloning and chromosomal assignment of the human brain-type phosphodiesterase I/Nucleotide Pyrophosphotase Gene (PDNP2). Genomics 30: 380-384, 1995
34. Murata J, Lee HY, Clair T, Krutzsch HC, Arestad AA, Sobel ME, Liotta LA, Stracke M: cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals ahomology with phosphodiesterase. J Biol Chem 269: 30479-30484, 1994
35. Deisler H, Lottspeich F, Rajewsky MF: Affinity purification and cDNA cloning of rat neural differentiation and tumor cell surface antigen gp 130 RB13-6 reveals relationship to human and murine PC-1. J Biol Chem 270: 9849-9855, 1995
36. Youngren J, Maddux BA, Sasson S, Sbraccia P, Tapscott EB, Swanson MS, Dohm GL, Goldfine ID: Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Diabetes 45: 1324-1328, 1996
37. Frittitta L, Youngren JF, Sbraccia P, D'Adamo M, Buongiorno A, Vigneri R Goldfine ID, Trischitta V: Increased adipose tissue PC-1 protein content but not TNF-α gene expression is associated to a reduction in whole body insulin sensitivity and insulin receptor tyrosine kinase activity. Diabetologia, March 1997, (in press)
38. Belli AI, van Driel IR, Goding JW: Identification and characterization of a soluble form of the plasma cell membrane glycoprotein PC-1 (5′-nucleotide phosphodiesterase) Endo J Biochem 217: 421-428, 1993
39. Grupe A, Alleman J, Goldfine ID, Sadick M, Stewart T: Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of Adenosine triphosphate or the generation of Adenosine. J Biol Chem 270: 22085-22088, 1995
40. Oda Y, Kuo M-D, Huang SS, Huang JS The plasma cell membrane glycoprotein, PC-1, is a threonine specific protein kinase stimulated by acidic fibroblast growth factor. J Biol Chem 266: 16791-16795, 1991
41. Stern MP, Duggurila R, Mitchell BD, Reinhart U, Shivakumar S, Shipman PA, Uresandi OC, Benavides E, Blangero J, O'Connell P: Evidence for linkage of regions on chromosomes 6 and 11 to plasma glucose concentrations in Mexican Americans. Genome Res 6: 724-734, 1996
42. Temple IK, Gardner RJ, Robinson DO, Kilbirige MS, Ferguson AW, Baum JD, Barber JCK, James RS, Shield JPH: Further evidence for an imprinted gene for neonatal diabetes localised to chromosome 6q22-q23. Human Mol Genet 5: 1117-1121, 1996
43. von Muhlendahl KE, Herkennoff H: Longterm course of neonatal diabetes. New Engl J Med 333: 704-708, 1995
44. Doria A, Federman S, Rich SS, Warram JH, Krolewski AS: DNA polymorphisms and mapping on chromosome 6q of plasma-cell antigen 1 (PC-1), an insulin signal inhibitor. Diabetologia 39 (suppl 1): A77, 1996
45. Sbraccia P, Goodman PA, Maddux B A, Chen Y-DI, Reaven GM, Goldfine ID: Production of an inhibitor of insulin receptor tyrosine kinase in fibroblasts from a patient with insulin resistance and NIDDM. Diabetes 40: 295-299, 1991
46. Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A, Spencer S, Grupe A, Henzel W, Stewart TA, Reaven GM, Goldfine ID: Membrane Glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes. Nature 373: 448-451, 1995
47. Whitehead JP, Humphreys PJ, Maasen JA, Moller DE, Krook A, O'Rahilly S: Increased PC-1 phosphodieste rase activity in patients with postreceptor insulin resistance but not in patients with insulin receptor mutations. Diabetologia [Suppl 1]:I-V, A65, 1995
48. Bonadonna RC, De Fronzo RA: Glucose metabolism in obesity and type 2 diabetes. Diabet Metab 17: 112-135, 1991
49. Frittitta L, Youngren J, Trischitta V, Goldfine ID: Membrane glycoprotein PC-1 content in skeletal muscle of non obese, non diabetic subjects: Relationship to insulin receptor tyrosine kinase activity and whole body insulin sensitivity. Diabetologia 39: 1190-1195, 1996
50. Reaven GM: The fourth musketeer, from Alexander Dumas to Claude Bernard. Diabetologia 38: 3-13, 1995
51. Milazzo G, Giorgino F, Damante G, Sung C, Stampfer MR, Vigneri R Goldfine ID, Belfiore A: Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 52: 3924-3930, 1992
52. Osborne CK, Monaco ME, Lippmann ME: Hormone responsive human breast cancer in long-term tissue culture: Effect on insulin. Proc Natl Acad Sci USA 73(12): 4536-4540, 1976
53. Ebina Y, Ellis L, Jamagin K, Edery M, Graf L, Clauser E, Ou J-H, Maslarz F, Kan YW, Goldfine ID, Roth RA, Rutter WJ: The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling. Cell 40: 747-758, 1985
54. Rousseau GG, Amar-Costesec A, Verhaegen M, Granner DK: Glucocorticoid hormones increase the activity of plasma membrane alkaline phosphodiesterase I in rat hepatoma cells. Proc Natl Acad Sci USA 77: 1005-1009, 1980
55. Buckley MF, Coding JW: Plasma cell membrane glycoprotein gene PC-1 (alkaline phosphodiesterase 1) is linked to the proto-oncogene Myb on mouse chromosome 10. Immunogenetics 36: 199-201, 1992